Urinary retention caused after fluoxetine-risperidone combination

Area of Science:

• Psychopharmacology
• Neuroscience

Background:

• Risperidone is an antipsychotic used for various psychiatric conditions.
• Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant.
• Combining psychotropic medications requires careful consideration of potential drug interactions.

Observation:

• A patient developed urinary retention and severe extrapyramidal side-effects (EPS) after initiating fluoxetine (20 mg/day) with low-dose risperidone (2 mg/day).

Findings:

• The combination of fluoxetine and risperidone may increase risperidone plasma concentrations.
• Fluoxetine itself may have an intrinsic propensity to cause EPS.
• Urinary retention could be linked to central serotonergic mechanisms, potentially exacerbated by D2 receptor blockade.

Implications:

• This case highlights the potential for significant adverse drug reactions when combining fluoxetine and risperidone.
• Understanding the pharmacodynamic and pharmacokinetic interactions is crucial for managing patients on combined therapy.
• Further research may be warranted to elucidate the precise mechanisms underlying these drug-induced side effects.